News: IMPAX Sued Based on ANDA for Generic Flomax(R). Genetic …
Tuesday, October 28th, 2008IMPAX Laboratories, Inc. today announced Boehringer Ingelheim
Pharmaceuticals Inc. (”Boehringer”) and Astellas Pharma Inc.
(”Astellas”) have filed suit for patent infringement in the United
States District Court for the Northern District of California based on
the Company’s submission of Abbreviated New Drug Application (”ANDA”)
for tamsulosin hydrochloride capsules (0.4 mg), generic of Flomax(R),
to the Food…
